In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice

Human Gene Therapy

Volumn 10, Issue 14, 1999, Pages 2373-2379

  Lukacs, Katalin V ^a,b   Porter, Colin D ^b   Pardo, Olivier E ^a   Oakley, Ruth E ^a   Steel, Rachel M ^a   Judd, Diane V ^a   Browning, James E ^a   Geddes, Duncan M ^a   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PLASMID DNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE THERAPY; IMMUNE DEFICIENCY; MARKER GENE; MESOTHELIOMA; MOUSE; NONHUMAN; NUDE MOUSE; RETROVIRUS; TUMOR GROWTH;

ANIMALS; BETA-GALACTOSIDASE; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, BACTERIAL; GENETIC VECTORS; LIPOSOMES; MESOTHELIOMA; MICE; MICE, INBRED CBA; MICE, NUDE; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; PLASMIDS; RETROVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0033588975     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017022     Document Type: Article

References (19)

1. ABINA, M.A., LEE, M.G., DESCAMPS, V., CORDIER, L., LOPEZ, M., PERRICAUDET, M., and HADDADA, H. (1996). lacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Gene Ther. 3, 212-216.
2. ALTON, E.W.F.W., MIDDLETON, P.C., CAPLEN, N.J., SMITH, S.N., STEEL, D.M., MUNKONGE, F.M., JEFFERY, P.K., GEDDES, D.M., HART, S.L., WILLIAMSON, R., FASOLD, K.I., MILLER, A.D., DICKINSON, P., STEVENSON, B.J. McLACHLAN, G., DORIN, J.R., and PORTEOUS, D.J. (1993). Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nature Genet. 5, 135-142.
3. COSSET, F.L., TAKEUCHI, Y., BATTINI, J.L., WEISS, R.A., and COLLINS, M.K. (1995). High titre packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
4. DAVIS, M.R., MANNING, L.S., WHITAKER, D., GARLEPP, M.J., and ROBINSON, B.W.S. (1992). Establishment of a murine model of malignant mesothelioma. Int. J. Cancer 52, 881-886.
5. FELGNER, J.H., KUMOR, R., SRIDHAR, C.N., WHEELER, C.J., TSAI, Y.J., BORDER, R., RAMSEY, P., MARTIN, P., and FELGNER, P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561.
6. GARRIDO, F., RUIZ-CABELLO, F., CABRERA, T., PEREZ-VILLAR, J.J., LOPEZ-BOTET, M., DUGGAN-KEEN, M., and STERN, P.L. (1997). Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today 2, 89-95.
7. KOTANI, H., NEWTON, P.B., III, ZHANG, S., CHIANG, Y.L., OTTO, E., WEAVER, L., BLAESE, R.M., ANDERSON, W.F., and McGARRITY, G.J. (1994). Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
8. LAMB, J.R., IVANYI, J., and REES, A.D.M. (1987). Mapping of T cells epitopes using recombinant antigens and synthetic peptides. EMBO J. 6, 1245-1249.
9. LOGAN, J.J., BEBOK, Z., WALKER, L.C., PENG, S., FELGNER, P.L., SIEGAL, G.P., FRIZZELL, R.A., DONG, J., and MATALON, H.M. (1995). Cationic lipids for reporter gene and CPTR transfer to rat pulmonary epithelium. Gene Ther. 2, 38-49.
10. LUKACS, K.V., LOWRIE, D.B., STOKES, R.W., and COLSTON, M.J. (1993). Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumours. J. Exp. Med. 178, 343-348.
11. LUKACS, K.V., LOWRIE, D.B., and COLSTON, M.J. (1996). Protection against tumors by stress protein gene transfer. In Stress Proteins in Medicine. W. van Eden and D.B. Young, eds. (Marcel Dekker, New York) pp. 249-265.
12. LUKACS, K.V., NAKAKES, A., LOWRIE, D.B., and COLSTEN, M.J. (1997). In vivo gene therapy of malignant tumours with heat shock protein-65 gene. Gene Ther. 4, 346-350.
13. MATZINGER, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
14. PISETSKY, D.S. (1997). Immunostimulatory DNA: A clear and present danger? Nature Med. 3, 829-831.
15. PORTER, C.D., LUKACS, K.V., BOX, G., TAKEUCHI, Y., and COLLINS, M.K.L. (1998). Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J. Virol. 72, 4832-4840.
16. ROMAN, M., MARTIN-OROZCO, E., GOODMAN, J.S., NGUYEN, M.D., SATO, Y., RONAGHY, A., KORNBLUTH, R.S., RICHMAN, D.D., CARSON, D.A., and RAZ, E. (1997). Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3, 849-854.
17. SLINGLUFF, C.L., JR., HUNT, D.F., and ENGELHARD, V.H. (1994). Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol. 6, 733-740.
18. SPARWASSER, T., KOCH, E.S., VABULAS, R.M., HEEG, K., LIPFORD, G.B., ELLWART, J.W., and WAGNER, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054.
19. TAKEHARA, T., HAYASHI, N., YAMAMOTO, M., MIYAMOTO, Y., FUSAMOTO, H., and KAMADA, T. (1996). In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA. Hum. Gene Ther. 7, 589-593.